Inflammatory bowel disease (IBD) is a type of immune-mediated chronic and relapsing
inflammatory gastrointestinal symptoms. IBD cannot be completely cured because of the …

Background and aims Inflammatory bowel disease (IBD) places a heavy medical burden on
countries and families due to repeated and prolonged attacks, and the incidence and …

Dysbiosis causes continuous progress of inflammatory bowel disease (IBD). Herein, we aim
to explore whether Salidroside (Sal), which is a major glycoside extracted from Rhodiola …

In clinical practice, fecal microbiota transplantation (FMT) has been used to treat
inflammatory bowel disease (IBD), and has shown certain effects. However, the selection of …

Prebiotics are effective in modulating gut microbiota and may further benefit colitis
remission. 2′-fucosyllactose (2′ FL) and galactooligosaccharide (GOS) are the main …

Glycerol monolaurate (GML) has potent antimicrobial and anti-inflammatory activities. The
present study aimed to assess the dose-dependent antimicrobial-effects of GML on the gut …

Correlations between gut microbiota activities and inflammatory bowel disease (IBD)
treatment are gaining research interest. In our previous study, Lactobacillus acidophilus …

Chicoric acid (CA) has been reported to exhibit biological activities; it remains unclear,
however, whether CA could regulate colitis via modulation of the gut microbiota and …

Scope Lactic acid bacteria with probiotic functions and their fermentation products play a
role in regulating ulcerative colitis (UC). This study investigates the potential role of …

Inflammatory bowel diseases (IBD) stem from alterations in the intestinal immune system
and microbial dysbiosis, but the precise interactions between bacteria and IBD remain …